SCHEDULE: American Century Funds Disclose Si-Bone Stake

American Century Mutual Funds, Investment Management, and related entities reported beneficial ownership of 5.3% of Si-Bone, Inc.'s common stock as of December 31, 2025.

Summary

• American Century Mutual Funds, Inc. beneficially owns 1,779,575 shares of Si-Bone, Inc. common stock, representing 4.1% of the class.
• American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research each beneficially own 2,300,508 shares of Si-Bone, Inc. common stock, representing 5.3% of the class.
• The beneficial ownership is reported as of December 31, 2025.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Si-Bone, Inc.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as increased institutional ownership by a reputable firm like American Century typically signals confidence in the company's long-term prospects and stability, without indicating any immediate operational changes.

Positives

• Increased institutional ownership by a reputable investment firm like American Century can signal confidence in Si-Bone, Inc.'s long-term prospects.
• The filing indicates a significant, passive investment, suggesting a belief in the company's current management and strategy.

Risks

• No specific risks related to Si-Bone, Inc.'s operations or financial health are disclosed in this Schedule 13G filing. The filing pertains to beneficial ownership by an investment group.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance from Si-Bone, Inc. regarding its future operations or financial performance.

Industry Context

StockSavvy.ai notes that an increase in institutional ownership, particularly by a well-established firm like American Century, can often be interpreted by the market as a vote of confidence in the issuer's business model and future growth potential within the medical device or healthcare sector. Such filings highlight the ongoing interest of large asset managers in specific companies.

Comparison to Industry Standards

• This filing is a standard disclosure of beneficial ownership and does not contain performance metrics for comparison to industry standards.
• StockSavvy.ai observes that institutional ownership levels vary widely across the medical technology sector, with established companies often having higher institutional holdings. The 5.3% stake by American Century represents a notable position for an institutional investor in Si-Bone, Inc.

Stakeholder Impact

• Shareholders: Existing shareholders may view this as a positive signal, potentially increasing investor confidence and demand for the stock.
• Management: The increased institutional stake could lead to greater scrutiny or engagement from a significant shareholder, though the filing states the investment is passive.

Key Dates

Recommendation

The filing indicates a significant institutional stake by American Century, suggesting a vote of confidence in Si-Bone, Inc. However, as a Schedule 13G, it provides no new operational or financial data to warrant a 'buy' or 'sell' recommendation. The 'hold' recommendation reflects the stability implied by institutional interest without new catalysts for immediate price movement.

Keywords

Si-Bone, SIBN, American Century, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Management, Medical Research